AlphaStocks

ICUI vs WST

As of Sep 20, 2026, ICU Medical (ICUI) scores 5.0/10 and West Pharmaceutical Services (WST) 7.4/10 on AlphaStocks' five-model composite, so WST scores higher. ICUI trades 73% above its model fair value; WST trades 81% above its model fair value.

ICUI

ICU MEDICAL INC/DE

5.0

Consider Buy

$152.43

WST

WEST PHARMACEUTICAL SERVICES INC

7.4

Consider Buy

$361.82

ICUI vs WST: Which is the Better Investment?

ICU MEDICAL INC/DE (ICUI) scores 5.0/10 while WEST PHARMACEUTICAL SERVICES INC (WST) scores 7.4/10 on AlphaStocks' composite model. WEST PHARMACEUTICAL SERVICES INC has the higher composite rating of Consider Buy. On a P/E basis, WEST PHARMACEUTICAL SERVICES INC trades at 53.3x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricICUIWST
Scores & Fundamentals
Composite Score5.0/107.4/10
RatingConsider BuyConsider Buy
Price$152.43$361.82
P/E Ratio5185.953.3
ROE0.0%11.4%
Market Cap$4B$26B
Fair Value$87.93$199.86
Dividend Yield
Sector Rank#110 of 168#10 of 168
Model Verdicts
PiotroskiAttractiveStrong
BuffettNeutralStrong
GrahamCautionNeutral
LynchNeutralNeutral
GreenblattCautionCaution
View full ICUIanalysis →View full WSTanalysis →

Related comparisons

Compare any two stocks →

ICUI vs WST: Which Stock Scores Higher?

ICU MEDICAL INC/DE (ICUI) and WEST PHARMACEUTICAL SERVICES INC (WST) are both in the Health Care sector. WST currently leads with a composite score of 7.4/10 (Consider Buy) compared to ICUI's 5.0/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer